Working Money magazine.  The investors' magazine. Advantage



Article Archive | Search | Subscribe/Renew | Login | Free Trial | Forgot ID?



Is Glaxo Smith/Kline Medicine For The Bull?

01/13/09 08:38:38 AM
by Koos van der Merwe

Glaxo Smith/Kline is a research-based pharmaceutical company that may be worth watching.

Security:   GSK
Position:   Accumulate

On October 9, 2008, Glaxo Smith/Kline (GSK) announced that Fluviral was available to Canadian private customers for the 2008–09 influenza season. The stock price surged up from a low of $32.84 to a high of $40.37, eventually reaching a high of $40.47 by November 4 before following the general market correction and finding a low of $31.10 by November 21.

FIGURE 1: GSK, DAILY. The stock price started rising as the general market rose to reach $37.95 by December 16.
Graphic provided by: AdvancedGET.
As you can see on Figure 1, the share price started rising as the general market rose to reach $37.95 by December 16. From this level, the price fell to $35.41 by December 29. The pattern that formed is an inverse head & shoulder pattern offering a target of $47.66 (39.38 - 31.10 = 8.28 + 39.38 = 47.66).

The chart shows where the stock price broke above the neckline, rising to a high of $39.60 before the present correction. I would have bought as the price broke above the correction. Is the price a buy at present levels? The stochastic oscillator (8,10,3) is suggesting that the price is at overbought levels and that we could expect a correction to test the support line. Should this occur? And should the stochastic be oversold and suggest a buy, I would be a buyer, with a target of $47.66.

This is a stock worth watching.

Koos van der Merwe

Has been a technical analyst since 1969, and has worked as a futures and options trader with First Financial Futures in Johannesburg, South Africa.

Address: 3256 West 24th Ave
Vancouver, BC
Phone # for sales: 6042634214
E-mail address:

Click here for more information about our publications!

Comments or Questions? Article Usefulness
5 (most useful)
1 (least useful)


S&C Subscription/Renewal

Request Information From Our Sponsors 

DEPARTMENTS: Advertising | Editorial | Circulation | Contact Us | BY PHONE: (206) 938-0570

PTSK — The Professional Traders' Starter Kit
Home — S&C Magazine | Working Money Magazine | Advantage | Online Store | Traders’ Resource
Add a Product to Traders’ Resource | Message Boards | Subscribe/Renew | Free Trial Issue | Article Code | Search

Copyright © 1982–2019 Technical Analysis, Inc. All rights reserved. Read our disclaimer & privacy statement.